Pharmaceutical Executive
Pharmaceutical Executive
Pharmaceutical Executive Podcast
Pharmaceutical Executive Daily: New Research Suggests Ozempic May Reduce Biological Age
3 minutes Posted Oct 27, 2025 at 8:20 pm.
0:00
3:06
Download MP3
Show notes
In today’s Pharmaceutical Executive Daily, we cover the FDA approval of Bayer’s Lynkuet for menopausal hot flashes, new research suggesting Ozempic may reduce biological age, and Novartis’ $12 billion merger agreement to acquire Avidity Biosciences.